Overview
Overview
Good Documentation Practices (GDP) and Data Integrity are crucial aspects of pharmaceutical manufacturing and are necessary to ensure the safety, quality, and efficacy of pharmaceutical products.
GDP refers to the guidelines and best practices for documentation in the pharmaceutical industry. The purpose of GDP is to ensure that all data, records, and documents related to the manufacturing process are accurate, complete, and easily traceable. GDP includes guidelines for document preparation, review, approval, storage, and retention.
Data Integrity refers to the completeness, accuracy, and consistency of data throughout its life cycle. It is essential to ensure that data generated during the manufacturing process is accurate and reliable, as it can have a significant impact on the safety and efficacy of pharmaceutical products.
In recent years, there have been numerous cases of data integrity violations in the pharmaceutical industry, leading to significant regulatory action, including product recalls and fines. To prevent such violations, regulatory agencies such as the FDA and EMA have issued guidelines on data integrity and require compliance with these guidelines as a part of the manufacturing process.
Learning Points:
GDP refers to the guidelines and best practices for documentation in the pharmaceutical industry. The purpose of GDP is to ensure that all data, records, and documents related to the manufacturing process are accurate, complete, and easily traceable. GDP includes guidelines for document preparation, review, approval, storage, and retention.
Data Integrity refers to the completeness, accuracy, and consistency of data throughout its life cycle. It is essential to ensure that data generated during the manufacturing process is accurate and reliable, as it can have a significant impact on the safety and efficacy of pharmaceutical products.
In recent years, there have been numerous cases of data integrity violations in the pharmaceutical industry, leading to significant regulatory action, including product recalls and fines. To prevent such violations, regulatory agencies such as the FDA and EMA have issued guidelines on data integrity and require compliance with these guidelines as a part of the manufacturing process.
Learning Points:
- Background, history, and regulatory requirements of Data Integrity (DI)
- Understanding the importance of DI
- Common Good documentation practices (GDP) with ALCOA+
- Overview of DI lifecycle management
- Knowledge on computer systems workflow and validation
- Audit trails, electronic data and records
- DI prevention by design
OUR STUDENTS WORK AT
NAI partners with industry-leading corporations and provides them with ready-on-day-one employees.
